BioCanRx is a network of scientists, clinicians, cancer stakeholders, NGOs and industry partners working together to accelerate the development of innovative cancer therapeutics. BioCanRx invests in Canadian innovations and the best the field has to offer, always looking for a clear path to the clinic for the benefit of patients. Through an innovative, collaborative, well-managed research funding process, BioCanRx is becoming a world-leader in the translation, manufacture and adoption of innovative cancer immunotherapies by leveraging expert knowledge of our network. We work in partnership with industry, academic institutions, charities and other not-for-profits to translate immune-based technologies from the lab into early phase clinical trials, and address socio-economic considerations necessary for their adoption by health-care systems. The network is attracting and developing the talent needed for a thriving health biotechnology sector in Canada. BioCanRx receives funding from the federal government’s Networks of Centres of Excellence, and support from industry, the provinces and many national charities.